Cortellis™ Clinical Trials Intelligence is the most powerful resource to accelerate clinical trial development decisions and portfolio strategy. Expertly curated clinical trials information is skillfully integrated with other scientific and competitive intelligence from Thomson Reuters. So you can make the most informed decision to direct your clinical strategies.
Navigating clinical trials in emerging markets and BRIC nations
Utilizing various adaptive trial designs, regulating clinical trial transparency
Enhance your Cortellis Competitive Intelligence subscription with access to the world’s most comprehensive Broker Research reports.
Rapid insight into critical deal making trends that allows you to uncover nuances in specific deal types.
Newport Premium™ (for Generics) Newport Premium™ (for Innovators) are used to find qualified sources of active ingredients. Newport products are now used by more than 350 companies operating in more than 50 countries around the world.
BioWorld™ Today delivers actionable intelligence on the biotech science that drives the business, which funds the means to heal disease.